Dr. Barbieri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
221 Longwood Ave
Boston, MA 02115- Is this information wrong?
Summary
- John Barbieri, MD, MBA is an Assistant Professor at Harvard Medical School and the Director of the Advanced Acne Therapeutics Clinic at the Brigham and Women’s Hospital. He is an associate editor at JAMA Dermatology and is also the co-chair of the American Academy of Dermatology Acne Guidelines Work Group. His research is focused on conducting innovative clinical trials, health economic, and epidemiology studies to identify the best approaches to care for patients with acne, rosacea, atopic dermatitis, psoriasis, and other chronic inflammatory skin diseases. He also focuses on exploring the role of patient-reported outcomes to ensure we are capturing the patient’s voice and perspective on their care.
Education & Training
- University of Pennsylvania Health SystemResidency, Dermatology, 2014 - 2018
- Perelman School of Medicine at the University of PennsylvaniaClass of 2014
- The Wharton SchoolMBA, 2014
Certifications & Licensure
- MA State Medical License 2021 - 2026
- OH State Medical License 2018 - 2021
- PA State Medical License 2014 - 2018
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study.Alice J Tan, Marjorie Archila, Aaron M Scherer, Lourdes M Perez-Chada, John S Barbieri, Arash Mostaghimi, Maryam M Asgari, Joel M Gelfand, Megan H Noe> ;Archives of Dermatological Research. 2024 Apr 18
- Potential Role of Calcitonin Gene-Related Peptide Inhibitors in the Treatment of Rosacea Flushing and Erythema.John S Barbieri> ;JAMA Dermatology. 2024 Apr 17
- Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort ...Christopher J Thang, David Garate, Sean O'Leary, George Golovko, Michael G Wilkerson, John S Barbieri> ;The British Journal of Dermatology. 2024 Mar 26
- Join now to see all
Journal Articles
- Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne with SpironolactoneJohn S Barbieri, David J Margolis, Arash Mostaghimi, JAMA Dermatology
- Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department VisitsJohn Barbieri, MD, JAMA Dermatology
- Use of Antibiotics for Dermatologic Procedures from 2008 to 2016Jeremy R Etzkorn, David J Margolis, John S Barbieri, JAMA
- Join now to see all
Authored Content
- Diet and Acne—Challenges of Translating Nutritional Epidemiologic Research into Clinical PracticeJune 2020
Press Mentions
- Spinosad: New Kid on the Block for Treating ScabiesMarch 15th, 2023
- Topical or Intralesional Cidofovir an Option for Recalcitrant WartsFebruary 28th, 2023
- Large Cohort Study Finds Isotretinoin Not Associated with IBDFebruary 6th, 2023
- Join now to see all
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: